The Citral Market, estimated at USD 3.19 Bn in 2025, is expected to exhibit a CAGR of 6.7% and reach USD 5.03 Bn by 2032.
The market outlook remains positive, driven by growing demand for healthy, natural, and sustainable food ingredients across diverse food and beverage categories. Advances in processing, sourcing, and product innovation are enhancing quality, nutrition, and consumer appeal. Moreover, companies are strengthening their presence through innovation, strategic partnerships, and expanded distribution networks to capture new growth opportunities.
Citral Market – Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China), in the last months of 2019, as "coronavirus disease 2019" or COVID-19. This virus spreads quickly, and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems regarding transportation of drugs from one place to another.
To curb the spread of the virus, governments worldwide mandated temporary shutdowns of manufacturing facilities, thus impacting the production of citral.
The pandemic has led to changes in consumer behavior, thus, accelerating the adoption of online shopping and affecting the types of products consumers prioritize. There is a shift towards products perceived as healthy or immunity-boosting, where citral applications could play a role.
The economic uncertainty and supply chain disruptions induced price volatility in the citral market, with producers and buyers facing challenges in forecasting and managing costs.
With the pandemic's strain on governmental agencies, there were delays in processing regulatory approvals, certifications, and meeting compliance requirements, thus, affecting new product launches and market entries involving citral.